{"transactions":[{"id":1410561,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":87640,"kind":"person","name":"Martin George Kelly","position":1,"cik":"0001982607","reported_name":"Martin George Kelly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-10T21:42:07.000Z","date":"2024-08-28","kind":"sale","planned":false,"acquired":false,"shares":9,"price":5.5,"value":49.5,"ownership":{"direct":false,"nature":"By Varka LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares are held by Varka LLC. The Reporting Person may be deemed to have beneficial ownership of the shares held directly by Varka LLC."}],"balance_after":247176,"source":{"system":"sec-edgar","filing":"0001415889-24-023167","document":"form4-09102024_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000141588924023167/form4-09102024_090904.xml","form_type":"4"}},{"id":1426230,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":87640,"kind":"person","name":"Martin George Kelly","position":1,"cik":"0001982607","reported_name":"Martin George Kelly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-08-22T00:43:48.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of August 13, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":5.75,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-021950","document":"form4-08222024_120845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000141588924021950/form4-08222024_120845.xml","form_type":"4"}},{"id":1808103,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":87640,"kind":"person","name":"Martin George Kelly","position":1,"cik":"0001982607","reported_name":"Martin George Kelly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-14T21:54:29.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":35000,"derivative":{"exercise_price":11.34,"expiration_date":"2033-08-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-045692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000120919123045692/doc4.xml","form_type":"4"}}]}